Cargando…

Circulating biomarkers for early detection of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is estimated to be the fourth leading cause of cancer-related deaths worldwide. HCC patients face a dismal prognosis because symptoms usually appear in an advanced stage of disease. The detection of early stage HCC allows for curative surgical treatment and therefore s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beudeker, Boris J. B., Boonstra, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325534/ https://www.ncbi.nlm.nih.gov/pubmed/32647536 http://dx.doi.org/10.1177/1756284820931734

Ejemplares similares

Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC
por: Beudeker, Boris J. B., et al.
Publicado: (2022)

Letter to the Editor: Entecavir Treatment Restores the Anti‐HBV Immune response?
por: Beudeker, Boris J.B., et al.
Publicado: (2021)

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
por: Debes, José D., et al.
Publicado: (2021)

Hepatitis B core‐related antigen levels predict recurrence‐free survival in patients with HBV‐associated early‐stage hepatocellular carcinoma: results from a Dutch long‐term follow‐up study
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
por: Beudeker, Boris J.B., et al.
Publicado: (2023)

Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
por: Balaceanu, Lavinia Alice
Publicado: (2019)

Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma
por: Salehi, Mahsa, et al.
Publicado: (2023)

Circulating Biomarkers for the Early Diagnosis and Management of Hepatocellular Carcinoma with Potential Application in Resource-Limited Settings
por: Pan, Annabelle, et al.
Publicado: (2023)

Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Afonso, Marta B., et al.
Publicado: (2016)

New Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Yoshida, Katsunori
Publicado: (2015)

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
por: Wu, Xiaolin, et al.
Publicado: (2020)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
por: Rico Montanari, Noe, et al.
Publicado: (2021)

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma
por: Chen, Tingsong
Publicado: (2022)

Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
por: Van Hees, Stijn, et al.
Publicado: (2016)

Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy
por: Spaan, Michelle, et al.
Publicado: (2016)

Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma
por: Liang, Wenjin, et al.
Publicado: (2022)

Surveillance programmes for early detection of hepatocellular carcinoma
por: Simon, Krzysztof, et al.
Publicado: (2012)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Li, Jie, et al.
Publicado: (2018)

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
por: Yang, Ju Dong
Publicado: (2019)

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
por: Zhu, Kai, et al.
Publicado: (2013)

Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
por: Chávez-López, María de Guadalupe, et al.
Publicado: (2016)

Combination of biomarkers for the detection of hepatocellular carcinoma
por: Sternby Eilard, Malin, et al.
Publicado: (2020)

Biomarkers for Hepatocellular Carcinoma
por: Behne, Tara, et al.
Publicado: (2012)

Biomarkers for Hepatocellular Carcinoma
por: Lou, Jiatao, et al.
Publicado: (2017)

Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment
por: Xing, Mengtao, et al.
Publicado: (2021)

Models of Hepatocellular Carcinoma and Biomarker Strategy
por: Bagi, Cedo M., et al.
Publicado: (2010)

Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
por: Chiappini, Franck
Publicado: (2012)

Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016)

Research progress on circulating tumor cells of hepatocellular carcinoma
por: Wan, Chenyu, et al.
Publicado: (2021)

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA
por: Campani, Claudia, et al.
Publicado: (2023)

Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
por: Cabral, Loraine Kay D., et al.
Publicado: (2022)

The Role of Artificial Intelligence in the Detection and Implementation of Biomarkers for Hepatocellular Carcinoma: Outlook and Opportunities
por: Mansur, Arian, et al.
Publicado: (2023)

Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma
por: Cho, Eun Ju, et al.
Publicado: (2019)

Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
por: Choi, Eun-Ji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ik4udebhiuq08bvukh975h8f6